Form 424B3 - Prospectus [Rule 424(b)(3)]
25 Julio 2024 - 4:16PM
Edgar (US Regulatory)
July 25, 2024 |
Registration Statement Nos. 333-270004
and 333-270004-01; Rule 424(b)(3) |
![](https://www.sec.gov/Archives/edgar/data/1665650/000101376224001197/image_001.jpg)
JPMorgan Chase Financial Company LLC
Structured Investments
Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the Nasdaq-100 Index® and the S&P 500® Index due July 22,
2027
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in
the pricing supplement dated July 19, 2024, related to the notes referred to above (the “pricing supplement”), the Fees and
Commissions and the Proceeds to Issuer are as set forth below:
|
Price to Public (1) |
Fees and Commissions (2)(3) |
Proceeds to Issuer |
Per note |
$1,000 |
$25 |
$975 |
Total |
$1,959,000 |
$48,975 |
$1,910,025 |
(1) See “Supplemental Use of Proceeds” in
the pricing supplement for information about the components of the price to public of the notes.
(2) J.P. Morgan Securities LLC, which we refer to as
JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $25.00 per $1,000 principal amount note it receives
from us to other affiliated or unaffiliated dealers. See “Plan of Distribution (Conflicts of Interest)” in the accompanying
product supplement.
(3) JPMS will pay a structuring fee of $8.00 per $1,000
principal amount note with respect to all of the notes to other affiliated or unaffiliated dealers. |
CUSIP: 48135N5K8
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk
Factors” beginning on page PS-11 of the accompanying product supplement and “Selected Risk Considerations” beginning
on page PS-4 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this amendment,
the pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus
addendum. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement
and the related product supplement, underlying supplement, prospectus supplement and prospectus and prospectus addendum, each of which
can be accessed via the hyperlinks below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.
· Pricing supplement dated July 19, 2024:
https://www.sec.gov/Archives/edgar/data/1665650/000121390024063654/ea177839_424b2.htm
· Product supplement no. 4-I dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf
· Underlying
supplement no. 1-I dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000121390023029543/ea151873_424b2.pdf
· Prospectus
supplement and prospectus, each dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf
· Prospectus
addendum dated June 3, 2024:
http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm
Amendment no. 1 to pricing supplement dated July 19, 2024
to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus
supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024
JP Morgan Chase (NYSE:JPM-M)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
JP Morgan Chase (NYSE:JPM-M)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024